[Skip to Content]
[Skip to Content Landing]
Article
March 7, 1959

CURRENT STATUS OF THERAPY IN BRONCHIAL ASTHMA

Author Affiliations

Boston

Clinical Professor of Medicine and Director, Lung Station (Tufts) and Department of Inhalation Therapy, Boston City Hospital.

JAMA. 1959;169(10):1063-1071. doi:10.1001/jama.1959.73000270005011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Bronchial asthma is a distressing and common form of acute, recurrent, or chronic bronchial inflammation and obstructive emphysema, usually of allergic origin. The acute paroxysm of bronchial asthma may last for hours or recur in varying degrees of severity for days. Finally, a state of intractable asthma, during which the episode is continuous and refractory to treatment, may result. In this state the patient presents a picture of marked physiological imbalance. Evidence of hypoxia, cyanosis, dehydration, disturbed psyche, peripheral vascular collapse, and further disturbances may be noted because of changes induced by the widespread use of drug therapy. Death is more commonly due to asphyxia resulting from the plugged and obliterated bronchi and bronchioles and from oversedation; it is also due to the failure of endogenous discharge of adrenal hormones necessary in the defense mechanism against stress, and, in more recent years, particularly to steroid sequelae.

Medical Management  The successful

First Page Preview View Large
First page PDF preview
First page PDF preview
×